Boston Scientific to cut 1,400 jobs

Boston Scientific will cut up to 1,400 jobs by the end of 2013 to save $275 million, the company revealed in its second quarter earnings report. The cuts will be achieved through a combination of employee attrition and targeted headcount reductions. Some of the money saved will be re-invested in areas the company is eyeing for future growth, such as emerging markets. The 25,000-person company added that it plans to create 1,000 new jobs in China over the next 5 years as part of a $150 million expansion in that country.

The medical devicemaker's sales totaled $1.975 billion in the second quarter. Its reported earnings of $0.10 per share represented a 66% increase over the second quarter of 2010. And its adjusted earnings per share of $0.17 was a 42% increase over the second quarter last year. Both beat the company's previous guidance.

The company also reduced its gross debt to $4.2 billion by prepaying the remaining $750 million of term loan borrowings during the quarter. Boston Scientific also announced its intention to buy back $1 billion in shares. "This repurchase program reflects our confidence in the strength of the company's long-term business prospects, earnings growth potential and our ability to generate strong cash flow," said outgoing CEO Ray Elliott in a statement.

- check out the Boston Sci earnings release 
- get the share buyback release
- read the Bloomberg article for more

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.